Skip to main content

and
  1. Article

    Open Access

    Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

    Ebola virus is the primary contributor to the global threat of filovirus severe hemorrhagic fever, and Ebola virus disease has a case fatality rate of 50–90%. An inactivated, bivalent filovirus/rabies virus va...

    Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J. Schnell in npj Vaccines (2023)

  2. Article

    Open Access

    Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity

    The objective of this study is to further analyze recombinant rabies virus-vectored SARS-CoV-2 vaccine, CORAVAX, as an effective COVID-19 vaccine strategy. CORAVAX has proven immunogenic and protective against...

    Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J. Schnell in npj Vaccines (2022)

  3. Article

    Open Access

    Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract

    Zika virus (ZIKV) can cause devastating effects in the unborn fetus of pregnant women. To develop a candidate vaccine that can protect human fetuses, we generated a panel of live measles vaccine (MV) vectors e...

    Drishya Kurup, Christoph Wirblich, Rachael Lambert, Leila Zabihi Diba in npj Vaccines (2022)

  4. Article

    Open Access

    A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

    The development of effective countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the COVID-19 pandemic, is a priority. We designed and produced ConVa...

    Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk in npj Vaccines (2021)

  5. Article

    Open Access

    Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2

    The recently emerged coronavirus SARS-CoV-2, the causative agent of COVID-19, is rapidly spreading in the world. The exponentially expanding threat of SARS-CoV-2 to global health highlights the urgent need for...

    Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J. Schnell in npj Vaccines (2020)

  6. Article

    Open Access

    Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus

    In the original published version of this Article, the figure legends were attached to the wrong figures. The legend for Fig. 2 was moved to Fig. 4, the legend for Fig. 3 was moved to Fig. 2, and the legend fo...

    Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup in npj Vaccines (2019)

  7. Article

    Open Access

    Rabies-based vaccine induces potent immune responses against Nipah virus

    Nipah Virus (NiV) is a re-emerging zoonotic pathogen in the genus Henipavirus of the Paramyxoviridae family of viruses. NiV is endemic to Bangladesh and Malaysia and is highly fatal to both livestock and humans (...

    Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup in npj Vaccines (2019)